Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy

被引:598
作者
Turer, Aslan T. [1 ]
Hill, Joseph A. [1 ,2 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
MITOCHONDRIAL PERMEABILITY TRANSITION; PERCUTANEOUS CORONARY INTERVENTION; BYPASS GRAFT-SURGERY; NO-REFLOW PHENOMENON; HYDROGEN EXCHANGE INHIBITION; FREE-RADICAL GENERATION; REDUCES INFARCT SIZE; NITRIC-OXIDE; CONTROLLED-TRIAL; CARDIAC-SURGERY;
D O I
10.1016/j.amjcard.2010.03.032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the initial description of the phenomenon by Jennings et al 50 years ago, our understanding of the underlying mechanisms of reperfusion injury has grown significantly. Its pathogenesis reflects the confluence of multiple pathways, including ion channels, reactive oxygen species, inflammation, and endothelial dysfunction. The purposes of this review are to examine the current state of understanding of ischemia-reperfusion injury, as well as to highlight recent interventions aimed at this heretofore elusive target. In conclusion, despite its complexity our ongoing efforts to mitigate this form of injury should not be deterred, because nearly 2 million patients annually undergo either spontaneous (in the form of acute myocardial infarction) or iatrogenic (in the context of cardioplegic arrest) ischemia-reperfusion. (C) 2010 Elsevier Inc. All rights reserved. (Am J Cardiol 2010;106: 360-368)
引用
收藏
页码:360 / 368
页数:9
相关论文
共 136 条
[1]   Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction [J].
Abbate, Antonio ;
Salloum, Fadi N. ;
Vecile, Elena ;
Das, Anindita ;
Hoke, Nicholas N. ;
Straino, Stefania ;
Biondi-Zoccai, Giuseppe G. L. ;
Houser, Jon-Erik ;
Qureshi, Ian Z. ;
Ownby, Evan D. ;
Gustini, Edoardo ;
Biasucci, Luigi M. ;
Severino, Anna ;
Capogrossi, Maurizio C. ;
Vetrovec, George W. ;
Crea, Filippo ;
Baldi, Alfonso ;
Kukreja, Rakesh C. ;
Dobrina, Aldo .
CIRCULATION, 2008, 117 (20) :2670-2683
[2]  
Alexander JH, 2008, JAMA-J AM MED ASSOC, V299, P1777, DOI 10.1001/jama.299.15.joc80027
[3]   Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial [J].
Amit, Guy ;
Cafri, Carlos ;
Yaroslavtsev, Sergei ;
Fuchs, Shmuel ;
Paltiel, Ora ;
Abu-Ful, Akram ;
Weinstein, Jean M. ;
Wolak, Arik ;
Ilia, Reuben ;
Zahger, Doran .
AMERICAN HEART JOURNAL, 2006, 152 (05) :887.e9-887.e14
[4]   INCREASED ISCHEMIC-INJURY BUT DECREASED HYPOXIC INJURY IN HYPERTROPHIED RAT HEARTS [J].
ANDERSON, PG ;
ALLARD, MF ;
THOMAS, GD ;
BISHOP, SP ;
DIGERNESS, SB .
CIRCULATION RESEARCH, 1990, 67 (04) :948-959
[5]  
[Anonymous], EFFECT ACADESINE RED
[6]  
Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43
[7]  
Assali AR, 2000, CATHETER CARDIO INTE, V51, P27, DOI 10.1002/1522-726X(200009)51:1<27::AID-CCD7>3.0.CO
[8]  
2-0
[9]  
ATTARIAN DE, 1981, J THORAC CARDIOV SUR, V81, P382
[10]   Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon [J].
Barcin, C ;
Denktas, AE ;
Lennon, RJ ;
Hammes, L ;
Higano, ST ;
Holmes, DR ;
Garratt, KN ;
Lerman, A .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 61 (04) :484-491